Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots-Reference-Cited by-同舟云学术

Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots

Published:2014 Issue:11 Volume:50 Page:1344-1346
ISSN:1359-7345
Container-title:Chem. Commun.
language:en
Short-container-title:Chem. Commun.

Author:

Al-Ogaidi Israa¹²³⁴⁵,Gou Honglei⁵⁶⁷,Aguilar Zoraida P.⁸⁹,Guo Shouwu¹⁰¹¹¹²¹³,Melconian Alice K.¹²³⁴,Al-kazaz Abdul Kareem A.¹²³⁴,Meng Fanke⁵⁶⁷,Wu Nianqiang⁵⁶⁷

Affiliation:

1. Department of Biotechnology

2. College of Science

3. University of Baghdad

4. Baghdad, Iraq

5. Department of Mechanical and Aerospace Engineering

6. West Virginia University

7. Morgantown, USA

8. Zystein, LLC.

9. Fayetteville, USA

10. Key Laboratory for Thin Film and Microfabrication of the Ministry of Education

11. Research Institute of Micro/Nano Science and Technology

12. Shanghai Jiao Tong University

13. Shanghai 200240, China

Abstract

A cancer biomarker immuno-sensor has been developed by utilizing the chemiluminescence resonance energy transfer to graphene quantum dots.

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2014/CC/C3CC47701K

Reference36 articles.

1. American Cancer Society , Cancer Facts & Figs. 2013 , Atlanta, GA, USA , 2013

2. Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels Within the Normal Range

3. Biomarkers for Early Detection of Ovarian Cancer

4. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

5. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-assembled prussian blue nanoparticles on MXene quantum dots modified AuNPs for sensitive and reproducible biosensing of ovarian specific antigen (CA-125);Microchemical Journal;2024-11

2. Nanotechnological Advances in the Diagnosis of Gynecological Cancers and Nanotheranostics;Current Pharmaceutical Design;2024-09

3. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

4. Recent advances in nanostructure-enhanced optical assays focused on luminescence-based biosensors for detection of cancer biomarkers;TrAC Trends in Analytical Chemistry;2024-07

5. Classification and applications of nanomaterials in vitro diagnosis;Heliyon;2024-06